Switch to
More onapp

Hester Biosciences Ltd

HESTERBIO
Health CareBiotechnology
SmallcapWith a market cap of ₹1,639 cr, stock is ranked 875
Low RiskStock is 1.98x as volatile as Nifty
1,858.8511.85 (+0.64%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareBiotechnology
SmallcapWith a market cap of ₹1,639 cr, stock is ranked 875
Low RiskStock is 1.98x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
41.66
PB RatioPB Ratio
6.13
Dividend YieldDiv. Yield
0.52%
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

0%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Hester Biosciences Limited is an India-based company engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. Its segments include Poultry Division and Large Animal Division. It provides over 40 products across poultry vaccines (live and inactivated), large animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. It manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and large animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. It offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

Financial TrendFinancial statements 

2019202020212022185.28189.64219.01249.1741.5729.1834.4239.34
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 16, 2022

Hester Biosciences Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Hester Biosciences Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Newspaper Advertisements 
Announced OnNov 7, 2022

Hester Biosciences Limited has informed the Exchange about Newspaper Advertisements | Download

Hester Biosciences Limited has informed the Exchange about Newspaper Advertisements | Download

Cash Dividend 
Ex. DateAug 11, 2022

Final • Div/Share: ₹ 10

See all events